Complaint
Dacarbazine is an antineoplastic drug mainly used for the treatment of melanoma, soft tissue tumors and malignant lymphomas. Tumor patients are generally weak, and attention should be paid to the patient's reaction to the drug during the infusion of this drug. The most direct adverse reaction of this drug is the decrease of white blood cells and platelets. The general appearance time is 2-3 weeks of medication, and it will basically return to normal after another 2 weeks. If it does not recover, it needs to do treatment to increase white blood cells.
| Foreign name Dacarbazine CAS No. 4342-03-4 Molecular formula C6H10N6O Properties This product is off-white or slightly reddish loose lump or powder. Molecular weight: 182.18 Storage Store below 5°C in an airtight place away from light. |
